Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C
- PMID: 32386320
- PMCID: PMC7690366
- DOI: 10.1093/neuonc/noaa117
Adult diffuse glioma GWAS by molecular subtype identifies variants in D2HGDH and FAM20C
Abstract
Background: Twenty-five germline variants are associated with adult diffuse glioma, and some of these variants have been shown to be associated with particular subtypes of glioma. We hypothesized that additional germline variants could be identified if a genome-wide association study (GWAS) were performed by molecular subtype.
Methods: A total of 1320 glioma cases and 1889 controls were used in the discovery set and 799 glioma cases and 808 controls in the validation set. Glioma cases were classified into molecular subtypes based on combinations of isocitrate dehydrogenase (IDH) mutation, telomerase reverse transcriptase (TERT) promoter mutation, and 1p/19q codeletion. Logistic regression was applied to the discovery and validation sets to test for associations of variants with each of the subtypes. A meta-analysis was subsequently performed using a genome-wide P-value threshold of 5 × 10-8.
Results: Nine variants in or near D-2-hydroxyglutarate dehydrogenase (D2HGDH) on chromosome 2 were genome-wide significant in IDH-mutated glioma (most significant was rs5839764, meta P = 2.82 × 10-10). Further stratifying by 1p/19q codeletion status, one variant in D2HGDH was genome-wide significant in IDH-mutated non-codeleted glioma (rs1106639, meta P = 4.96 × 10-8). Further stratifying by TERT mutation, one variant near FAM20C (family with sequence similarity 20, member C) on chromosome 7 was genome-wide significant in gliomas that have IDH mutation, TERT mutation, and 1p/19q codeletion (rs111976262, meta P = 9.56 × 10-9). Thirty-six variants in or near GMEB2 on chromosome 20 near regulator of telomere elongation helicase 1 (RTEL1) were genome-wide significant in IDH wild-type glioma (most significant was rs4809313, meta P = 2.60 × 10-10).
Conclusions: Performing a GWAS by molecular subtype identified 2 new regions and a candidate independent region near RTEL1, which were associated with specific glioma molecular subtypes.
Keywords: GWAS glioma; allergy; glioblastoma; molecular subtype.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: [email protected].
Figures




Similar articles
-
TERT promoter mutation confers favorable prognosis regardless of 1p/19q status in adult diffuse gliomas with IDH1/2 mutations.Acta Neuropathol Commun. 2020 Nov 23;8(1):201. doi: 10.1186/s40478-020-01078-2. Acta Neuropathol Commun. 2020. PMID: 33228806 Free PMC article.
-
Diffuse gliomas classified by 1p/19q co-deletion, TERT promoter and IDH mutation status are associated with specific genetic risk loci.Acta Neuropathol. 2018 May;135(5):743-755. doi: 10.1007/s00401-018-1825-z. Epub 2018 Feb 19. Acta Neuropathol. 2018. PMID: 29460007 Free PMC article.
-
RNA editing-based classification of diffuse gliomas: predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion.BMC Bioinformatics. 2019 Dec 24;20(Suppl 19):659. doi: 10.1186/s12859-019-3236-0. BMC Bioinformatics. 2019. PMID: 31870275 Free PMC article.
-
The T2-FLAIR-mismatch sign as an imaging biomarker for IDH and 1p/19q status in diffuse low-grade gliomas: a systematic review with a Bayesian approach to evaluation of diagnostic test performance.Neurosurg Focus. 2019 Dec 1;47(6):E13. doi: 10.3171/2019.9.FOCUS19660. Neurosurg Focus. 2019. PMID: 31786548
-
Inherited genetics of adult diffuse glioma and polygenic risk scores-a review.Neurooncol Pract. 2022 Mar 12;9(4):259-270. doi: 10.1093/nop/npac017. eCollection 2022 Aug. Neurooncol Pract. 2022. PMID: 35859544 Free PMC article. Review.
Cited by
-
Epidemiological characteristics and genetic alterations in adult diffuse glioma in East Asian populations.Cancer Biol Med. 2022 Nov 1;19(10):1440-59. doi: 10.20892/j.issn.2095-3941.2022.0418. Cancer Biol Med. 2022. PMID: 36350002 Free PMC article. Review.
-
New alleles of D-2-hydroxyglutarate dehydrogenase enable studies of oncometabolite function in Drosophila melanogaster.bioRxiv [Preprint]. 2025 May 22:2025.03.27.645621. doi: 10.1101/2025.03.27.645621. bioRxiv. 2025. Update in: G3 (Bethesda). 2025 Jun 09:jkaf132. doi: 10.1093/g3journal/jkaf132. PMID: 40236175 Free PMC article. Updated. Preprint.
-
Functional germline variants in DNA damage repair pathways are associated with altered survival in adults with glioma treated with temozolomide.medRxiv [Preprint]. 2024 Oct 10:2023.10.13.23296963. doi: 10.1101/2023.10.13.23296963. medRxiv. 2024. Update in: Neuro Oncol. 2025 Jun 21;27(5):1385-1398. doi: 10.1093/neuonc/noae275. PMID: 39417102 Free PMC article. Updated. Preprint.
-
Genome-wide Polygenic Risk Scores Predict Risk of Glioma and Molecular Subtypes.medRxiv [Preprint]. 2024 Jan 11:2024.01.10.24301112. doi: 10.1101/2024.01.10.24301112. medRxiv. 2024. Update in: Neuro Oncol. 2024 Oct 3;26(10):1933-1944. doi: 10.1093/neuonc/noae112. PMID: 38260701 Free PMC article. Updated. Preprint.
-
Genetic predisposition to altered blood cell homeostasis is associated with glioma risk and survival.Nat Commun. 2025 Jan 14;16(1):658. doi: 10.1038/s41467-025-55919-6. Nat Commun. 2025. PMID: 39809742 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA139020/CA/NCI NIH HHS/United States
- HHSN261201800032C/CA/NCI NIH HHS/United States
- HHSN261201800009C/CA/NCI NIH HHS/United States
- P50 CA108961/CA/NCI NIH HHS/United States
- R01 CA230712/CA/NCI NIH HHS/United States
- R25 CA112355/CA/NCI NIH HHS/United States
- HHSN261201800015I/CA/NCI NIH HHS/United States
- R01 CA126831/CA/NCI NIH HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- HHSN261201800032I/CA/NCI NIH HHS/United States
- HHSN261201800015C/CA/NCI NIH HHS/United States
- NU58DP006344/DP/NCCDPHP CDC HHS/United States
- RC1 NS068222/NS/NINDS NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- P30 CA082103/CA/NCI NIH HHS/United States
- R01 CA207360/CA/NCI NIH HHS/United States
- R01 CA163687/CA/NCI NIH HHS/United States
- R01 CA052689/CA/NCI NIH HHS/United States
- HHSN261201800009I/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases